Total Payments
$6,941
2024 Payments
$20.08
Companies
32
Transactions
398
Medicare Patients
2,783
Medicare Billing
$277,135
Payment Breakdown by Category
Food & Beverage$6,306 (90.9%)
Travel$565.45 (8.1%)
Education$69.41 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,306 | 390 | 90.9% |
| Travel and Lodging | $565.45 | 1 | 8.1% |
| Education | $69.41 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,413 | 111 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $956.82 | 44 | $0 (2021) |
| Tandem Diabetes Care, Inc. | $741.67 | 8 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $643.96 | 28 | $0 (2022) |
| Amgen Inc. | $525.75 | 32 | $0 (2019) |
| Lilly USA, LLC | $374.01 | 31 | $0 (2022) |
| Valeritas, Inc. | $282.84 | 18 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $234.10 | 24 | $0 (2018) |
| Radius Health, Inc. | $197.16 | 21 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $194.57 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.08 | 2 | Novo Nordisk Inc ($14.96) |
| 2023 | $197.30 | 2 | Abbott Laboratories ($110.87) |
| 2022 | $511.15 | 17 | SANOFI-AVENTIS U.S. LLC ($281.81) |
| 2021 | $423.80 | 21 | Novo Nordisk Inc ($317.12) |
| 2020 | $251.12 | 9 | Novo Nordisk Inc ($122.89) |
| 2019 | $465.54 | 22 | Novo Nordisk Inc ($177.19) |
| 2018 | $2,680 | 130 | Tandem Diabetes Care, Inc. ($714.22) |
| 2017 | $2,393 | 195 | AstraZeneca Pharmaceuticals LP ($399.87) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $5.12 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 12/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $110.87 | General |
| Category: Diabetes Care | ||||||
| 02/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $86.43 | General |
| Category: DIABETES | ||||||
| 12/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $103.67 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Diabetes | ||||||
| 09/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Diabetes | ||||||
| 08/10/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/30/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/13/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $90.80 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/09/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/09/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/26/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $82.46 | General |
| Category: Diabetes | ||||||
| 04/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 03/18/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/21/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $81.32 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 02/01/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Diabetes | ||||||
| 01/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Diabetes | ||||||
| 12/26/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes Care | ||||||
| 12/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Diabetes | ||||||
| 11/16/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: Diabetes | ||||||
| 11/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 658 | 2,494 | $261,973 | $72,233 |
| 2022 | 8 | 626 | 2,215 | $236,400 | $66,091 |
| 2021 | 8 | 709 | 2,267 | $254,134 | $72,303 |
| 2020 | 12 | 790 | 2,677 | $280,274 | $66,508 |
Total Patients
2,783
Total Services
9,653
Medicare Billing
$277,135
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 343 | $99,813 | $27,730 | 27.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,320 | $80,520 | $24,054 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 122 | $24,522 | $7,064 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $19,404 | $5,194 | 26.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 61 | 116 | $14,616 | $2,838 | 19.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 132 | 256 | $8,960 | $2,418 | 27.0% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 15 | 51 | $9,945 | $1,894 | 19.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 121 | 219 | $3,066 | $839.30 | 27.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 23 | $1,127 | $201.78 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 376 | $109,416 | $31,411 | 28.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,080 | $65,880 | $18,482 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 115 | $23,115 | $6,943 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $13,230 | $3,445 | 26.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 131 | 265 | $9,275 | $2,468 | 26.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 45 | 89 | $11,214 | $2,225 | 19.8% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 127 | 242 | $3,388 | $920.13 | 27.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 18 | $882.00 | $196.94 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 200 | 426 | $123,966 | $37,349 | 30.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 13 | 900 | $51,240 | $13,409 | 26.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 70 | 70 | $30,870 | $8,296 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 114 | $22,914 | $6,850 | 29.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 153 | 337 | $11,795 | $3,243 | 27.5% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 28 | 62 | $7,812 | $1,659 | 21.2% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 156 | 343 | $4,802 | $1,332 | 27.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 15 | $735.00 | $164.10 | 22.3% |
About Dr. William Smith, M.D
Dr. William Smith, M.D is a Internal Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1730366519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Smith, M.D has received a total of $6,941 in payments from pharmaceutical and medical device companies, with $20.08 received in 2024. These payments were reported across 398 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,306).
As a Medicare-enrolled provider, Smith has provided services to 2,783 Medicare beneficiaries, totaling 9,653 services with total Medicare billing of $277,135. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location High Point, NC
- Active Since 01/24/2008
- Last Updated 12/06/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730366519
Products in Payments
- FARXIGA (Drug) $956.82
- t-slim insulin pump (Device) $741.67
- Ozempic (Drug) $704.39
- V-GO (Device) $299.89
- Victoza (Drug) $272.84
- INVOKANA (Drug) $214.44
- Prolia (Biological) $211.32
- TOUJEO (Drug) $206.42
- JARDIANCE (Drug) $206.34
- Repatha (Biological) $199.23
- Tymlos (Biological) $197.16
- Astral (Device) $177.16
- TOUJEO (Biological) $172.12
- RYBELSUS (Drug) $160.65
- BASAGLAR (Drug) $159.28
- AFREZZA (Drug) $128.46
- SOLIQUA (Drug) $128.01
- Dexcom G5 Mobile CGM System (Device) $125.51
- FREESTYLE LIBRE 3 (Device) $110.87
- SOLIQUA 100/33 (Biological) $109.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in High Point
Imran Haque, M.d, M.D
Internal Medicine — Payments: $18,695
Internal Medicine $18,695
Dr. Jeffrey Yourshaw, M.d, M.D
Internal Medicine — Payments: $12,650
Internal Medicine $12,650
Dr. Oscar Florendo, M.d, M.D
Internal Medicine — Payments: $11,971
Internal Medicine $11,971
Thomas Jarrett, M.d, M.D
Internal Medicine — Payments: $9,588
Internal Medicine $9,588
Kurt Daniel, D.o, D.O
Internal Medicine — Payments: $7,198
Internal Medicine $7,198
Dr. Fernando Sanchez-Brugal, Md, MD
Internal Medicine — Payments: $6,214
Internal Medicine $6,214